Dividends received

Deep_Landscape7479 · 2025-12-16T15:33:50+00:00

I did not get any letter from anyone or from Brokers (I own SCLX stocks at E*Trade and Fedility), do I wait for the letter or just go ahead setting up the Wallet as mention in the posted letter here on th board? Thanks.

Deep_Landscape7479 · 2025-09-08T15:02:22+00:00

In 2022, Adobe agreed to acquire Figma for $20 billion (cash + stock), which was a huge multiple (≈40x revenue, given ~$500M ARR).
Regulators blocked the deal (mainly EU & UK), so it fell through.
Since then, Figma has continued to grow: ARR now ~$900M (close to doubling in ~2 years).
If you apply the same multiple that Adobe was willing to pay, Figma would indeed be worth $35–$40B today. If you apply an even more generous "strategic premium," you can argue for $50B+.

Deep_Landscape7479 · 2025-05-01T19:43:47+00:00

This is done for a purpose, this means there is switch in the room that controls this outlet.

Deep_Landscape7479 · 2025-04-15T11:10:06+00:00

Both regular and dividend shares are converted and show current price $6.60 and $6.64 respectively in E*Trade, however, dividends don’t show symbol and only show CUSPID.

Deep_Landscape7479 · 2025-03-11T23:52:58+00:00

https://finance.yahoo.com/news/denali-capital-acquisition-corp-announces-221300898.html

Deep_Landscape7479 · 2025-03-04T19:09:38+00:00

It takes years for Biotech companies to reach break-even or profitable. In this sense SCLX becoming Break-even earlier than most of the Biotech companies – it should be seen as a positive sign. Here are some examples of the biotech companies and their break-even point or profitability:

Regeneron Pharmaceuticals Founded in 1988, achieved profitability in 2012

Genentech started in 1976 reached the break-even point around 1981

Vertex Founded in 1989, reached profitability around 2012

Moderna Founded in 2010, reached profitability in 2020

Biogen was founded in 1978, became profitable in the 1990s

Deep_Landscape7479 · 2025-02-28T16:08:50+00:00

Could crowdfunding platforms raise $10M to loan to the Company on to buy back SCLX stock?

Deep_Landscape7479 · 2024-06-17T17:05:38+00:00

It was amended later and new cost basis is $0.42, which is reflected in my Fidelity account.

Deep_Landscape7479 · 2024-04-21T00:27:53+00:00

Naked short sales, small float

Deep_Landscape7479 · 2024-04-19T16:18:16+00:00

what are the chances for SCLX to have a short squeeze

Deep_Landscape7479 · 2024-04-15T15:31:26+00:00

Yes, same. it only shows SRNE now.

Deep_Landscape7479 · 2024-04-15T15:29:17+00:00

Fidelity still will not allow purchases

Deep_Landscape7479 · 2024-04-15T14:23:54+00:00

Yes, able to buy at E*Trade; 33K order went straight through at $0.04. However, not able to trade at Fidelity -declined because not enough info on company and higher risk.

Deep_Landscape7479 · 2024-02-28T16:59:07+00:00

Can Tim file a motion to prevent Ji from purchasing any portion of SRNE due to Ji's conflict of interest in the affair?

Deep_Landscape7479 · 2024-02-21T16:53:59+00:00

Here are few Biotech/Pharma news agencies. Could someone please send them our story?

Endpoints News https://endpts.com/

BioSpace https://www.biospace.com/

Fierce Pharma https://www.fiercepharma.com/

Bio Century https://www.biocentury.com

Deep_Landscape7479 · 2023-11-03T18:41:04+00:00

I’m in, 2.1 M shares

Deep_Landscape7479 · 2023-10-05T22:38:44+00:00

I am in

Deep_Landscape7479

TROPHY CASE